Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.140
+0.050 (1.62%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Evolent Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 353 | 446 | 1,311 | 3,762 | 2,807 | 2,469 | |
Market Cap Growth | -69.61% | -65.96% | -65.14% | 34.01% | 13.70% | 82.57% |
Enterprise Value | 1,197 | 1,258 | 2,052 | 4,378 | 3,080 | 2,407 |
Last Close Price | 3.14 | 4.00 | 11.25 | 33.03 | 28.08 | 27.67 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 13.52 | 16.88 | 13.66 | 38.40 | 44.32 | 57.19 |
PEG Ratio | - | 1.91 | 1.91 | 1.91 | 1.91 | 1.91 |
PS Ratio | 0.19 | 0.24 | 0.51 | 1.92 | 2.08 | 2.72 |
PB Ratio | 0.89 | 1.08 | 1.31 | 3.52 | 3.27 | 3.56 |
P/FCF Ratio | 59.93 | 93.88 | - | 33.04 | - | 179.36 |
P/OCF Ratio | 10.61 | 11.49 | 69.88 | 26.38 | - | 63.71 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.63 | 0.67 | 0.80 | 2.23 | 2.28 | 2.65 |
EV/EBITDA Ratio | - | - | 26.34 | 83.87 | 43.49 | 136.57 |
EV/EBIT Ratio | - | - | - | - | 845.80 | - |
EV/FCF Ratio | 203.05 | 264.59 | - | 38.46 | - | 174.89 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.46 | 2.35 | 0.69 | 0.59 | 0.55 | 0.39 |
Debt / EBITDA Ratio | - | - | 9.16 | 12.35 | 6.72 | 15.91 |
Debt / FCF Ratio | 706.40 | 208.14 | - | 5.66 | - | 20.38 |
Net Debt / Equity Ratio | 2.07 | 1.96 | 0.55 | 0.41 | 0.32 | -0.09 |
Net Debt / EBITDA Ratio | -2.68 | -2.76 | 7.06 | 8.39 | 3.86 | -3.49 |
Net Debt / FCF Ratio | 587.40 | 170.71 | -89.78 | 3.85 | -5.48 | -4.47 |
Asset Turnover | 1.00 | 0.84 | 0.98 | 0.87 | 0.84 | 0.65 |
Quick Ratio | 1.26 | 1.27 | 0.81 | 0.97 | 1.06 | 1.06 |
Current Ratio | 1.32 | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
Return on Equity (ROE) | -122.77% | -75.47% | -5.96% | -11.73% | -2.41% | -4.61% |
Return on Assets (ROA) | -22.23% | -18.46% | -1.52% | -1.77% | 0.07% | -3.09% |
Return on Invested Capital (ROIC) | -34.38% | -29.52% | -2.59% | -3.01% | 0.12% | -6.74% |
Return on Capital Employed (ROCE) | -27.83% | -24.54% | -2.11% | -4.20% | 0.31% | -4.37% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | 1.67% | 1.07% | - | 3.03% | - | 0.56% |
Buyback Yield / Dilution | 1.41% | 0.41% | -3.08% | -18.73% | -8.87% | -1.34% |
Total Shareholder Return | 1.41% | 0.41% | -3.08% | -18.73% | -8.87% | -1.34% |